🔎 Trials Near Me

Home › Mitral Valve Insufficiency › Arizona › Phoenix

Mitral Valve Insufficiency clinical trials in Phoenix, AZ

7 studies for Mitral Valve Insufficiency are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Recruiting
  • Abrazo Heart Hospital, Phoenix
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642

Cephea Early Feasibility Study

Recruiting
  • Banner-University Medical Center Phoenix, Phoenix
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT05061004

Abbott Cephea Mitral Valve Disease Registry

RecruitingObservational study
  • Banner-University Medical Center Phoenix, Phoenix
  • Phoenix Cardiovascular Research Group, Phoenix
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07069673

ATLAS (AltaValve) Pivotal Trial

Recruiting
  • Banner University Medical Center, Phoenix
  • Abrazo Arizona Heart Hospital, Phoenix
  • Dignity Health; St. Joseph's Hospital and Medical Center, Phoenix
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT06465745

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Recruiting
  • Banner Health - Phoenix, Phoenix
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152

The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

Recruiting
  • Banner - University Medicine Cardiology Clinic, Phoenix
Ages 18 and older · All sexes · Updated Jan 13, 2026 · NCT04408430

AMEND TS Early Feasibility Study

Recruiting
  • Banner University Medical Center - Phoenix, Phoenix
Ages 21 and older · All sexes · Updated Jan 7, 2026 · NCT06951672

Mitral Valve Insufficiency trials in other cities

Other studies in Phoenix

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.